Peroxiredoxin6, a multitask antioxidant enzyme involved in the pathophysiology of chronic noncommunicable diseases

Francesca Pacifici, David Della Morte, Barbara Capuani, Donatella Pastore, Alfonso Bellia, Paolo Sbraccia, Nicola Di Daniele, Renato Lauro, Davide Lauro

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Significance: Chronic noncommunicable diseases (NCDs) are the leading causes of disability and death worldwide. NCDs mainly comprise diabetes mellitus, cardiovascular diseases, chronic obstructive pulmonary disease, cancer, and neurological degenerative diseases, which kill more than 80% of population, especially the elderly, worldwide. Recent Advances: Several recent theories established NCDs as multifactorial diseases, where a combination of genetic, epigenetic, and environmental factors contributes to their pathogenesis. Nevertheless, recent findings suggest that the common factor linking all these pathologies is an increase in oxidative stress and the age-related loss of the antioxidant mechanisms of defense against it. Impairment in mitochondrial homeostasis with consequent deregulation in oxidative stress balance has also been suggested. Critical Issues: Therefore, antioxidant proteins deserve particular attention for their potential role against NCDs. In particular, peroxiredoxin(Prdx)6 is a unique antioxidant enzyme, belonging to the Prdx family, with double properties, peroxidase and phospholipase activities. Through these activities, Prdx6 has been shown to be a powerful antioxidant enzyme, implicated in the pathogenesis of different NCDs. Recently, we described a phenotype of diabetes mellitus in Prdx6 knockout mice, suggesting a pivotal role of Prdx6 in the pathogenesis of cardiometabolic diseases. Future Directions: Increasing awareness on the role of antioxidant defenses in the pathogenesis of NCDs may open novel therapeutic approaches to reduce the burden of this pandemic phenomenon. However, knowledge of the role of Prdx6 in NCD prevention and pathogenesis is still not clarified.

Original languageEnglish (US)
Pages (from-to)399-414
Number of pages16
JournalAntioxidants and Redox Signaling
Volume30
Issue number3
DOIs
StatePublished - Jan 20 2019
Externally publishedYes

Fingerprint

Chronic Disease
Antioxidants
Enzymes
Oxidative stress
Medical problems
Peroxiredoxin VI
Diabetes Mellitus
Oxidative Stress
Peroxiredoxins
Phospholipases
Pandemics
Pulmonary diseases
Epigenomics
Knockout Mice
Deregulation
Chronic Obstructive Pulmonary Disease
Peroxidase
Pathology
Cause of Death
Lung Neoplasms

Keywords

  • antioxidant
  • peroxiredoxin6
  • senescence
  • type 2 diabetes mellitus

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Peroxiredoxin6, a multitask antioxidant enzyme involved in the pathophysiology of chronic noncommunicable diseases. / Pacifici, Francesca; Della Morte, David; Capuani, Barbara; Pastore, Donatella; Bellia, Alfonso; Sbraccia, Paolo; Di Daniele, Nicola; Lauro, Renato; Lauro, Davide.

In: Antioxidants and Redox Signaling, Vol. 30, No. 3, 20.01.2019, p. 399-414.

Research output: Contribution to journalReview article

Pacifici, F, Della Morte, D, Capuani, B, Pastore, D, Bellia, A, Sbraccia, P, Di Daniele, N, Lauro, R & Lauro, D 2019, 'Peroxiredoxin6, a multitask antioxidant enzyme involved in the pathophysiology of chronic noncommunicable diseases', Antioxidants and Redox Signaling, vol. 30, no. 3, pp. 399-414. https://doi.org/10.1089/ars.2017.7427
Pacifici, Francesca ; Della Morte, David ; Capuani, Barbara ; Pastore, Donatella ; Bellia, Alfonso ; Sbraccia, Paolo ; Di Daniele, Nicola ; Lauro, Renato ; Lauro, Davide. / Peroxiredoxin6, a multitask antioxidant enzyme involved in the pathophysiology of chronic noncommunicable diseases. In: Antioxidants and Redox Signaling. 2019 ; Vol. 30, No. 3. pp. 399-414.
@article{c622f0c9c60445809a60b8f755ac51ec,
title = "Peroxiredoxin6, a multitask antioxidant enzyme involved in the pathophysiology of chronic noncommunicable diseases",
abstract = "Significance: Chronic noncommunicable diseases (NCDs) are the leading causes of disability and death worldwide. NCDs mainly comprise diabetes mellitus, cardiovascular diseases, chronic obstructive pulmonary disease, cancer, and neurological degenerative diseases, which kill more than 80{\%} of population, especially the elderly, worldwide. Recent Advances: Several recent theories established NCDs as multifactorial diseases, where a combination of genetic, epigenetic, and environmental factors contributes to their pathogenesis. Nevertheless, recent findings suggest that the common factor linking all these pathologies is an increase in oxidative stress and the age-related loss of the antioxidant mechanisms of defense against it. Impairment in mitochondrial homeostasis with consequent deregulation in oxidative stress balance has also been suggested. Critical Issues: Therefore, antioxidant proteins deserve particular attention for their potential role against NCDs. In particular, peroxiredoxin(Prdx)6 is a unique antioxidant enzyme, belonging to the Prdx family, with double properties, peroxidase and phospholipase activities. Through these activities, Prdx6 has been shown to be a powerful antioxidant enzyme, implicated in the pathogenesis of different NCDs. Recently, we described a phenotype of diabetes mellitus in Prdx6 knockout mice, suggesting a pivotal role of Prdx6 in the pathogenesis of cardiometabolic diseases. Future Directions: Increasing awareness on the role of antioxidant defenses in the pathogenesis of NCDs may open novel therapeutic approaches to reduce the burden of this pandemic phenomenon. However, knowledge of the role of Prdx6 in NCD prevention and pathogenesis is still not clarified.",
keywords = "antioxidant, peroxiredoxin6, senescence, type 2 diabetes mellitus",
author = "Francesca Pacifici and {Della Morte}, David and Barbara Capuani and Donatella Pastore and Alfonso Bellia and Paolo Sbraccia and {Di Daniele}, Nicola and Renato Lauro and Davide Lauro",
year = "2019",
month = "1",
day = "20",
doi = "10.1089/ars.2017.7427",
language = "English (US)",
volume = "30",
pages = "399--414",
journal = "Antioxidants and Redox Signaling",
issn = "1523-0864",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Peroxiredoxin6, a multitask antioxidant enzyme involved in the pathophysiology of chronic noncommunicable diseases

AU - Pacifici, Francesca

AU - Della Morte, David

AU - Capuani, Barbara

AU - Pastore, Donatella

AU - Bellia, Alfonso

AU - Sbraccia, Paolo

AU - Di Daniele, Nicola

AU - Lauro, Renato

AU - Lauro, Davide

PY - 2019/1/20

Y1 - 2019/1/20

N2 - Significance: Chronic noncommunicable diseases (NCDs) are the leading causes of disability and death worldwide. NCDs mainly comprise diabetes mellitus, cardiovascular diseases, chronic obstructive pulmonary disease, cancer, and neurological degenerative diseases, which kill more than 80% of population, especially the elderly, worldwide. Recent Advances: Several recent theories established NCDs as multifactorial diseases, where a combination of genetic, epigenetic, and environmental factors contributes to their pathogenesis. Nevertheless, recent findings suggest that the common factor linking all these pathologies is an increase in oxidative stress and the age-related loss of the antioxidant mechanisms of defense against it. Impairment in mitochondrial homeostasis with consequent deregulation in oxidative stress balance has also been suggested. Critical Issues: Therefore, antioxidant proteins deserve particular attention for their potential role against NCDs. In particular, peroxiredoxin(Prdx)6 is a unique antioxidant enzyme, belonging to the Prdx family, with double properties, peroxidase and phospholipase activities. Through these activities, Prdx6 has been shown to be a powerful antioxidant enzyme, implicated in the pathogenesis of different NCDs. Recently, we described a phenotype of diabetes mellitus in Prdx6 knockout mice, suggesting a pivotal role of Prdx6 in the pathogenesis of cardiometabolic diseases. Future Directions: Increasing awareness on the role of antioxidant defenses in the pathogenesis of NCDs may open novel therapeutic approaches to reduce the burden of this pandemic phenomenon. However, knowledge of the role of Prdx6 in NCD prevention and pathogenesis is still not clarified.

AB - Significance: Chronic noncommunicable diseases (NCDs) are the leading causes of disability and death worldwide. NCDs mainly comprise diabetes mellitus, cardiovascular diseases, chronic obstructive pulmonary disease, cancer, and neurological degenerative diseases, which kill more than 80% of population, especially the elderly, worldwide. Recent Advances: Several recent theories established NCDs as multifactorial diseases, where a combination of genetic, epigenetic, and environmental factors contributes to their pathogenesis. Nevertheless, recent findings suggest that the common factor linking all these pathologies is an increase in oxidative stress and the age-related loss of the antioxidant mechanisms of defense against it. Impairment in mitochondrial homeostasis with consequent deregulation in oxidative stress balance has also been suggested. Critical Issues: Therefore, antioxidant proteins deserve particular attention for their potential role against NCDs. In particular, peroxiredoxin(Prdx)6 is a unique antioxidant enzyme, belonging to the Prdx family, with double properties, peroxidase and phospholipase activities. Through these activities, Prdx6 has been shown to be a powerful antioxidant enzyme, implicated in the pathogenesis of different NCDs. Recently, we described a phenotype of diabetes mellitus in Prdx6 knockout mice, suggesting a pivotal role of Prdx6 in the pathogenesis of cardiometabolic diseases. Future Directions: Increasing awareness on the role of antioxidant defenses in the pathogenesis of NCDs may open novel therapeutic approaches to reduce the burden of this pandemic phenomenon. However, knowledge of the role of Prdx6 in NCD prevention and pathogenesis is still not clarified.

KW - antioxidant

KW - peroxiredoxin6

KW - senescence

KW - type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=85058678520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058678520&partnerID=8YFLogxK

U2 - 10.1089/ars.2017.7427

DO - 10.1089/ars.2017.7427

M3 - Review article

C2 - 29160110

AN - SCOPUS:85058678520

VL - 30

SP - 399

EP - 414

JO - Antioxidants and Redox Signaling

JF - Antioxidants and Redox Signaling

SN - 1523-0864

IS - 3

ER -